The focus of the Montine Laboratory is on the structural and molecular bases of cognitive impairment with the goal of defining key pathogenic steps and thereby new therapeutic targets.
The Montine Laboratory addresses these prevalent, unmet medical needs through a combination of neuropathology, biomarker development and application early in the course of disease, and experimental studies that test hypotheses concerning specific mechanisms of neuron injury and approaches to neuroprotection.
Prof. Montine is the founding Director of the Pacific Udall Center and the Neuropathology and Biospecimens Core leader of the Stanford Alzheimer’s Disease Center.
